Burcon Nutrascience Corporation BU.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 922.00K | 602.30K | 530.20K | 259.30K | 247.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 922.00K | 602.30K | 530.20K | 259.30K | 247.30K |
| Cost of Revenue | 2.46M | 2.54M | 1.67M | 1.53M | 1.36M |
| Gross Profit | -1.54M | -1.94M | -1.14M | -1.27M | -1.11M |
| SG&A Expenses | 569.10K | 547.40K | 519.00K | 584.90K | 510.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.19M | 3.03M | 2.44M | 2.37M | 2.04M |
| Operating Income | -2.27M | -2.43M | -1.91M | -2.11M | -1.79M |
| Income Before Tax | -2.88M | -2.91M | -2.56M | -2.61M | -2.51M |
| Income Tax Expenses | -149.70K | -284.20K | -- | -- | -- |
| Earnings from Continuing Operations | -2.73M | -2.62M | -2.56M | -2.61M | -2.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73M | -2.62M | -2.56M | -2.61M | -2.51M |
| EBIT | -2.27M | -2.43M | -1.91M | -2.11M | -1.79M |
| EBITDA | -- | -2.38M | -1.87M | -2.07M | -1.50M |
| EPS Basic | -0.22 | -0.21 | -0.20 | -0.21 | -0.20 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.13 | -0.13 | -0.12 |
| EPS Diluted | -0.22 | -0.21 | -0.20 | -0.21 | -0.20 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.13 | -0.13 | -0.12 |
| Average Basic Shares Outstanding | 12.69M | 12.69M | 12.69M | 12.69M | 12.69M |
| Average Diluted Shares Outstanding | 12.69M | 12.69M | 12.69M | 12.69M | 12.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |